World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
109
Citations
52655
World Ranking
514
National Ranking
313

Medicine

D-Index
109
Citations
52798
World Ranking
5705
National Ranking
3068

Michael M. Lederman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael M. Lederman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 496 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael M. Lederman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael M. Lederman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 109 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2011 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Michael M. Lederman is affiliated with Case Western Reserve University in the United States. Their research spans multiple disciplines within medicine, particularly focusing on immunology, microbiology, and infectious diseases.

The primary fields of study for Michael M. Lederman include:

  • Medicine
  • Immunology and Microbiology

Subfields of their work cover:

  • Infectious Diseases
  • Virology
  • Immunology
  • Emergency Medicine
  • Epidemiology

Research topics central to Michael M. Lederman's work include:

  • HIV Research and Treatment
  • HIV-related health complications and treatments
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research
  • Atherosclerosis and Cardiovascular Diseases

Their notable recent publications include:

  • SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy, 2020, published in EBioMedicine
  • Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy, 2023, published in Cell Host & Microbe
  • Translocated microbiome composition determines immunological outcome in treated HIV infection, 2021, published in Cell
  • Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop, 2020, published in Pathogens and Immunity
  • Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus, 2021, published in Clinical Infectious Diseases

Michael M. Lederman frequently collaborates with the following researchers:

  • Michael L. Freeman
  • Steven G. Deeks
  • Nicholas Funderburg
  • Daniela Moïsi
  • Peter W. Hunt

Their publications often appear in these journals and venues:

  • Pathogens and Immunity
  • UNC Libraries
  • Frontiers in Immunology
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases

Michael M. Lederman has been recognized by professional organizations with distinctions such as:

  • Fellow of the American Association for the Advancement of Science (AAAS), 2011
  • Member of the Association of American Physicians

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher

  • HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells

    Michael R. Betts;Martha C. Nason;Sadie M. West;Stephen C. De Rosa

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

    Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker

  • Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism

    Ivan Vujkovic-Cvijin;Richard M. Dunham;Shoko Iwai;Michael C. Maher

  • Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection

    Wei Jiang;Michael M. Lederman;Peter Hunt;Scott F. Sieg

  • HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.

    Sergio Serrano-Villar;Talia Sainz;Sulggi A. Lee;Peter W. Hunt

  • A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia

    James J. Goedert;Craig M. Kessler;Louis M. Aledort;Robert J. Biggar

  • Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

    Michael Marcel Lederman;Elizabeth Connick;Alan Landay;Daniel R. Kuritzkes

  • Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment

    Allan R. Tenorio;Yu Zheng;Ronald J. Bosch;Supriya Krishnan

  • Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication

    Miguel E Quiñones-Mateu;Michael M Lederman;Zhimin Feng;Bikram Chakraborty

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

    Peter W. Hunt;Elizabeth Sinclair;Benigno Rodriguez;Carey Shive

  • A potential role for interleukin-7 in T-cell homeostasis

    Terry J. Fry;Elizabeth Connick;Judith Falloon;Michael Marcel Lederman

  • Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5

    Michael M Lederman;Ronald S Veazey;Robin Ewart Offord;Donald E Mosier

  • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

    Craig W. Hendrix;Ann C. Collier;Michael Marcel Lederman;Dominique Schols

  • Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2

    Nicholas Funderburg;Michael M. Lederman;Zhimin Feng;Michael G. Drage

  • Impaired Cell-Mediated Immunity in Patients with Classic Hemophilia

    Michael M. Lederman;Oscar D. Ratnoff;James J. Scillian;Paul K. Jones

  • Inadequate T follicular cell help impairs B cell immunity during HIV infection

    Rafael A. Cubas;Joseph C. Mudd;Anne Laure Savoye;Matthieu Perreau

  • Perforin Expression Directly Ex Vivo by HIV-Specific CD8 + T-Cells Is a Correlate of HIV Elite Control

    Adam R. Hersperger;Florencia Pereyra;Martha Nason;Korey R. Demers

  • Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

    Benigno Rodríguez;Ajay K. Sethi;Vinay K. Cheruvu;Wilma Mackay

  • IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.

    Irini Sereti;Richard M. Dunham;John Spritzler;Evgenia Aga

  • Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients.

    R. A. Salata;M. M. Lederman;D. M. Shlaes;M. R. Jacobs

Frequent Co-Authors

Benigno Rodriguez
Benigno Rodriguez Case Western Reserve University
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Nicholas T. Funderburg
Nicholas T. Funderburg The Ohio State University
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Peter W. Hunt
Peter W. Hunt University of California, San Francisco
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Grace A. McComsey
Grace A. McComsey Case Western Reserve University
Ronald J. Bosch
Ronald J. Bosch Harvard University
Clifford V. Harding
Clifford V. Harding Case Western Reserve University
Daniel C. Douek
Daniel C. Douek National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related degrees can open up diverse career opportunities in healthcare and research. Many students pivot to advanced nursing roles after foundational studies, making programs like the fnp to acnp pathway a popular choice for expanding clinical expertise.

Accelerated programs offer a fast-track route for students seeking to enter the field swiftly. The accelerated nurse practitioner program is ideal for those with previous healthcare experience aiming for advanced practice roles without spending years in school.

For individuals new to nursing, the online ABSN programs for non nurses provide accessible pathways to obtain a Bachelor of Science in Nursing, which can be foundational for immunology-related healthcare careers.

Additionally, if entry requirements are a concern, researching the easiest accelerated nursing programs can help prospective students find programs that balance quality education with manageable admissions criteria.

Best Scientists Citing Michael M. Lederman

Trending Scientists